
0:00
30:22
In this episode of Without Boundaries, host Jon Eggins sits down with Matt DeCicco, a leader on Lord Abbett’s equity investment team and portfolio manager on the firm’s Innovation Growth Equity team, with a focus on biotech and healthcare innovation. With an MS in Biotechnology, Matt combines deep scientific expertise with decades of equity investing experience.
Topics include:
• Why biotech investing is a repeatable process even when revenues are years away
- The small-cap opportunities in oncology and rare diseases
- How conviction, clinical evidence and price trends impact portfolio allocations
- The role of AI in speeding drug discovery and creating differentiation across companies
- Developing Russell Investments’ customized biotech strategy for high-growth healthcare
More episodes from "Without Boundaries"



Don't miss an episode of “Without Boundaries” and subscribe to it in the GetPodcast app.








